Skip to main content
Equibles
CBT logo

CBT · Cabot Corp · Metrics

Track CBT — free

Use CBT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CBT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$78.32 -1.03 (-1.30%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$4.05B
Shares
51.63M

CBT metrics

94 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$79.35
Market cap
$4.05B

Price action

20 metrics
Price change (1W)
-0.4%
Price change (30D)
-7.1%
Price change (3M)
-4.8%
Price change (6M)
+16.8%
Price change (YTD)
+21.2%
Price change (1Y)
-1.0%
Trailing year
Price change (5Y)
+56.3%
52-week high
$93.40
52-week low
$58.71
Change from 52-week high
-14.0%
Change from 52-week low
+36.8%
Annualized volatility
33.1%
Annualized volatility (3M)
36.6%
Beta
0.6
RSI (14D)
37.1
Price vs SMA 50
-7.2%
Price vs SMA 200
+3.4%
Avg volume (3M)
502,006
Relative volume
0.6
Average dollar volume
$43.95M

Company

3 metrics
Sector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
51.63M

Valuation

12 metrics
P / E (TTM)
22.6
Trailing earnings · reciprocal yield 4.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.1×
reciprocal yield 87.4%
P / book
2.6
reciprocal yield 38.6%
FCF yield
6.8%
TTM · current market cap
Buyback yield
3.4%
P / FCF
14.8
reciprocal yield 6.8%
P / operating cash flow
8.4
reciprocal yield 11.9%
Earnings yield
4.0%

Historical valuation

8 metrics
P / E historical average (3Y)
13.0×
reciprocal yield 7.7%
P / E historical average (5Y)
16.1×
reciprocal yield 6.2%
EV / revenue historical average (3Y)
1.4×
reciprocal yield 71.4%
EV / revenue historical average (5Y)
1.3×
reciprocal yield 75.5%
EV / EBIT historical average (3Y)
9.3×
reciprocal yield 10.8%
EV / EBIT historical average (5Y)
10.6×
reciprocal yield 9.4%
EV / EBITDA historical average (3Y)
7.3×
reciprocal yield 13.7%
EV / EBITDA historical average (5Y)
7.9×
reciprocal yield 12.6%

Dividends & buybacks

7 metrics
Dividend yield
2.3%
Trailing 12 months
Payout ratio
57.7%
Shareholder yield
5.7%
Dividend / share (TTM)
$1.85
Dividend growth YoY
+4.9%
Dividend growth streak
5
Last ex-dividend
2026-08-28

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
22.7%
Operating margin
13.6%
Trailing 12 months
Net margin
4.6%
Gross profit (TTM)
$825.00M
Operating profit (TTM)
$493.00M
Net income (TTM)
$168.00M
Trailing 12 months
Diluted EPS (TTM)
$3.56
FCF margin
7.7%
Effective tax rate
46.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$29.33

Growth

11 metrics
Revenue growth YoY
+6.4%
Year over year
Net income growth YoY
-94.1%
Revenue (TTM)
$3.63B
Trailing 12 months
EPS growth YoY
-93.5%
Shares change YoY
-3.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.9%
Revenue CAGR (5Y)
+7.3%
EPS CAGR (3Y)
+18.5%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+17.2%

Quality

14 metrics
Return on equity
10.5%
Return on assets
4.2%
Debt / equity
0.7
Current ratio
1.5
EBITDA (TTM)
$673.00M
Free cash flow (TTM)
$281.00M
Quick ratio
1.0
Interest coverage
6.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$250.00M
Total assets
$3.98B
Total debt
$1.09B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$497.00M
Capital expenditures (TTM)
$216.00M
R&D (TTM)
$55.00M
SG&A (TTM)
$277.00M
Stock compensation (TTM)
$18.00M
R&D / revenue
1.5%
Stock compensation / revenue
0.5%

Ownership (13F)

3 metrics
13F filers
392
13F filer change QoQ
+16
Institutional ownership
104.5%

Short interest

3 metrics
Short interest
8.0%
Latest settlement · 7.1 days to cover
Days to cover
7.1d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$19.65M
Insider-sentiment score
22 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 16040 CUSIP 127055101 13F (30d) 192 filings 191 filers Visit website Investor relations